NHS Digital is providing an additional list of newly identified patients to add to the Shielded Patient List (SPL), which in turn makes them a high priority for COVID-19 vaccination.
Latest News
dm+d Changes to Pfizer/BioNTech Covid-19 Vaccine
As you will be aware, the rollout of the COVID-19 vaccination is now taking place across the UK. We have been working closely with each national body and we would like to share with you the following update on our progress and short term implementation plans.
As there can be a delay in health boards transferring out deceased patients, there is a chance that you will generate invitations and recalls for them. This can, understandably, be very distressing for the deceased patient’s family. Unfortunately, Clinical Audit cannot look at Registration Links data, so to ensure you do not raise invitations and recalls for your recently deceased patients, you should run a search on the group.
The Coronavirus Vaccination Monitoring audit has been updated.
As you are aware all adults in England with Down’s Syndrome should be identified and reviewed by practices for inclusion on the Shielded Patient List (SPL)
We have updated the COVID Guideline to include a vaccination management section which allows for quick and easy data display and data entry.
• Adult Patients with Down's Syndrome - All adults in England with Down’s Syndrome should be identified and reviewed by practices for inclusion on the Shielded Patient List (SPL). • Stage 5 Chronic Kidney Disease (CKD) – All patients with Stage 5 CKD are being contacted with regards to Coronavirus shielding. For your information the definition of Stage 5 CKD is: • Chronic kidney disease is defined as a reduction in kidney function or structural damage, or both, present for more than 3 months. • CKD stage 5, or G5 A1-3, is defined as a GFR less than 15 ml/min. Note - Stage 5 CKD excludes individuals who transiently drop below 15 ml/min, for example, acute kidney injury, acute on chronic kidney disease. We have updated the Coronavirus clinical audits to support these updates: • Click here for the latest In Practice Systems Daily audit. • Click here for details on how to download audits. NHS Digital have provided us with an updated Shielded Patient letter for your patients who qualify for the SPL and for patients that newly qualify for the SPL based on the above criteria. We have turned these into Vision template letters, which can be downloaded from the following links: • High risk patients - 201104_Highest_risk_additions_letter_1K. • Down’s Syndrome Patients: • Standard - 201104_Highest_risk_additions_letter_Downs_syndrome. • Easy Read - EasyRdLetter_DownSyndrome_Final 02 11 20. Important - We recommend that both Down’s syndrome letters are provided to the patient. • Stage 5 CKD - 201104_Highest_risk_additions_letter_CKD. Remember – These are templates, you can update them to your practice format as required.
Update - Coding of Household Contacts of Coronavirus (COVID-19) Shielding Patients
Tags: Coronavirus
Update - Coding of Coronavirus (COVID-19) Shielding Patients
Pillar 2 SARS-Cov-2 Antibody test results are shortly due to start to flow into Patient Records. As these come from the same trading partner that Pillar 2 Virus RNA Detection results use, X-Labs National Pathology Exchange (NPEx) no action is required.